Blood Donor Eligibility. Shan Yuan, MD October 5 th, 2010



Similar documents
BLOOD DONOR TESTING & LOOKBACK STUDIES Shan Yuan, MD Last Updated 2/8/ ABO Typing: Performed each time with each donation

Determining Donor Eligibility Blood Donor vs. Stem Cell Donor. Wanda Koetz, RN, HPC Clinical Nurse Lead, Memorial Blood Centers ASFA - May 7, 2015

DHQ v eff. May 2008

The Osler Institute. Blood Bank II. D. Joe Chaffin, MD Cedars-Sinai Medical Center, Los Angeles, CA

The Basics of Blood Donation

Medical Questionnaire and Informed Consent Public Cord Blood Bank Switzerland

Department of Transfusion Medicine and Immunohematology

William Atkinson, MD, MPH Hepatitis B Vaccine Issues June 16, 2016

Appendix 3 Exposure Incident Report Form

ALLIED HEALTH AND NURSING PROGRAM HEALTH REQUIREMENTS

Blood & Marrow Transplant Glossary. Pediatric Blood and Marrow Transplant Program Patient Guide

Blood Transfusion. There are three types of blood cells: Red blood cells. White blood cells. Platelets.

EPIDEMIOLOGY OF HEPATITIS B IN IRELAND

Dear Parents, Enclosed are all the forms you will need to register for cord blood storage. We have tried to make the process as simple as possible:

LABORATORY PROCEDURE MANUAL

CONGRATULATIONS! We re pleased that you chose to preserve your baby s newborn stem cells with ViaCord.

AUTOLOGOUS BLOOD DONATION

When an occupational exposure occurs, the source patient should be evaluated for both hepatitis B and hepatitis C. (AII)

For Parents and Students: Minor Donor Permit and Information About Donating Blood

Viral Safety of Plasma-Derived Products

Yes, I know I have genital herpes:

VACCINATIONS FOR ADULT HORSES

ATBF Comment to. February This response only includes those items wherein the ATBF wishes to submit comments at this time.

2015 Outpatient Chronic Hepatitis B Management

National Health Burden of CLD in Italy

PREVENTIVE HEALTHCARE GUIDELINES INTRODUCTION

Viral Hepatitis Case Report

POST-EXPOSURE PROPHYLAXIS IN THE HEALTH CARE SETTING

english facts about hepatitis A, B and C

FAQs HIV & AIDS. What is HIV? A virus that reduces the effectiveness of your immune system, meaning you are less protected against disease.

Preventive Care Coverage Wondering what preventive care your plan covers?

12/2/2015 HEPATITIS B AND HEPATITIS C BLOOD EXPOSURE OBJECTIVES VIRAL HEPATITIS

Minor Consent Form. Attention Parent or Guardian: Please Read, Complete and Sign Form

Commonly Asked Questions About Chronic Hepatitis C

Multiple Choice Questions

ALBERTA BLOOD AND MARROW TRANSPLANT PROGRAM NEW GUIDELINES FOR THE IMMUNIZATION OF HEMATOPOIETIC STEM CELL TRANSPLANT(HSCT) RECIPIENTS JULY 11, 2013

Chickenpox and Shingles Vaccines

Preventive health guidelines As of May 2015

Frozen Donor Embryo Transfer Price List, EDI 2016

BLOOD COLLECTION. How much blood is donated each year and how much is used?

HUNTER COLLEGE OF THE CITY UNIVERSITY OF NEW YORK HUNTER-BELLEVUE SCHOOL OF NURSING HEALTH REQUIREMENTS AND CLINICAL PRACTICE CLEARANCE

Blood, Plasma, and Cellular Blood Components INTRODUCTION

APPLICATION FOR LICENSURE OF A BLOOD BANK (Under the Provisions of N.J.S.A. 26:2A et seq.)

Preventive Health Guidelines

Immunization Information for Blinn College Students

Premarital Screening Standard. Premarital Screening and Counseling Program. Version 1.1

Preventive health guidelines As of May 2014

AMERICAN HERITAGE LIFE INSURANCE COMPANY (AHL) 1776 AMERICAN HERITAGE LIFE DRIVE JACKSONVILLE, FLORIDA 32224

Preventing Cervical Cancer with Gardasil Jana Ogden RN, MSN, MBA-HCA, IHCC Nursing Faculty. Upon Completion of the Lesson the student will be able to:

Blood Transfusion. Red Blood Cells White Blood Cells Platelets

Background: 1) Does your center have effective ways of collecting data from multiple sources to submit to multiple organizations?

The Danish Bone Marrow Donor Registry DBMDR

160S01105, Page 1 of 7. Human Hepatitis B Immunoglobulin, solution for intramuscular injection.

Introduction to Blood Management

HEPATITIS WEB STUDY Acute Hepatitis C Virus Infection: Epidemiology, Clinical Features, and Diagnosis

EDUCATIONAL COMMENTARY TESTING BLOOD DONORS FOR COMMUNICABLE DISEASES

Chapter 21. What Are HIV and AIDS?

Infectious Disease Markers (IDMs) Data

The Epidemiology of Hepatitis A, B, and C

Guidelines for Viral Hepatitis CTR Services

Are Booster Doses of Hepatitis B Vaccine Necessary?

FDA Considerations Regarding Frequent Plasma Collection Procedures

Zika Virus. Fred A. Lopez, MD, MACP Richard Vial Professor Department of Medicine Section of Infectious Diseases

Explanation of requirements for clinical experiences HFU

Donor Adverse Events

Explanation of Immunization Requirements

VACCINATIONS FOR FOALS

Hepatitis B Virus (Pregnancy) Investigation Guideline

Mother s blood test to check her unborn baby s blood group

4/30/2013 HPV VACCINE AND NORTH DAKOTA HPV IMMUNIZATION RATES HUMAN PAPILLOMAVIRUS (HPV) HUMAN PAPILLOMAVIRUS HPV CONTINUED

Preventive Care Guideline for Asymptomatic Low Risk Adults Age 18 through 64

Guidelines for Vaccinating Pregnant Women

INITIATING ORAL AUBAGIO (teriflunomide) THERAPY

Frequently Asked Questions

POST EXPOSURE PROPHYLAXI S

Name Date Class. This section explains what kinds of organisms cause infectious disease and how infectious diseases are spread.

BASIC INFORMATION ABOUT HIV, HEPATITIS B and C, and TUBERCULOSIS Adapted from the CDC

GUIDE TO FOLLOW UP TESTING FOR BLOOD OR BODY FLUID EXPOSURES AND NEEDLESTICK INJURIES

Preventive health guidelines

I B2.4. Design of the patient information leaflet for VariQuin

Patient Information Sheet

Clinical/Field Pre-Placement Health Form

OCCUPATIONAL HEALTH, DISABILITY AND LEAVE SECTOR MEASURES TO MINIMIZE EXPOSURE TO BLOODBORNE PATHOGENS AND POST-EXPOSURE PROPHYLAXIS POLICY

Title: Post Exposure Prophylaxis Page 1 of 8 Policy No: 1 CLN 010 Effective Date 04/15/11

Bloodborne Pathogens (HIV, HBV, and HCV) Exposure Management

Series 1 Case Studies Adverse Events that Represent Unanticipated Problems: Reporting Required

Procedure Code(s): n/a This counseling service is included in a preventive care wellness examination or focused E&M visit.

Coding and Billing for HIV Services in Healthcare Facilities

SECTION SEVEN INSTITUTIONAL POLICIES RELATIVE TO GME PROGRAMS POLICY NO: 7. 6 SUBJECT: EMPLOYEE HEALTH SERVICE PROCEDURES AND GUIDELINES

MUSC Occupational Blood Borne Pathogen Protocol Off-Campus Procedure Packet

The Immune System and Disease

LAB 14 ENZYME LINKED IMMUNOSORBENT ASSAY (ELISA)

HIV/AIDS: General Information & Testing in the Emergency Department

These are illnesses which might not only spoil your holiday but might also pose a risk to your life.

Preventive Services for Pregnancy SERVICE WHAT IS COVERED INTERVALS OF COVERAGE Anemia Screening Screening Annual screening for pregnant women

Take advantage of preventive care to help manage your health

THE A, B, C S OF HEPATITIS. Matt Eidem, M.D. Digestive Health Associates of Texas 1600 Coit Road Suite #301 Plano, Texas (972)

Cancer of the Cervix

Introduction Hemophilia is a rare bleeding disorder in which the blood does not clot normally. About 1 in 10,000 people are born with hemophilia.

What is a Stem Cell Transplantation?

Transcription:

Blood Donor Eligibility Shan Yuan, MD October 5 th, 2010

Question 1 Which of the following blood donors is eligible for allogeneic whole blood donation? A. 88yo F, Hgb=12.5g/dL, weight 116 lbs B. 36 yo M, HR 60, BP 160/90, RR 12/min, temperature 99.6F C. 22 yo F, HR 48, long distance runner, Hgb=11.8g/dL D. 15 yo F, HR 78, BP 120/80, RR 13/min, temperature 99.0F, donating at high school drive

Explanation Age: Must be at least 17 yo, or 16 yo with parental consent in some states. No upper age limit Physical Requirements

Question 1 Which of the following blood donors is eligible for allogeneic whole blood donation? A. 88yo F, Hgb=12.5g/dL, weight 116 lbs B. 36 yo M, HR 60, BP 160/90, RR 12/min, temperature 99.6F C. 22 yo F, HR 48, long distance runner, Hgb=11.8g/dL D. 15 yo F, HR 78, BP 120/80, RR 13/min, temperature 99/0F, donating at high school drive

Question 2 Which of the following is NOT a cause for permanent donor deferral? A. IV drug use B. Male-to-male sex, once in 1976 C. History of Babesiosis or Chagas Disease D. Received drugs for sex once in 1996 E. History of viral hepatitis at the age of 13

Explanation Causes of Permanent Deferrals: High-risk behavior for HIV/viral hepatitis infection: IVDA Male-male sex after 1977 Prostitution Viral hepatitis after 11 th birthday Tested positive for any of the HIV, HBV, HCV, HTLV tests, except anti-hbc History of babesiosis or Chagas Disease Malignancy: leukemia or lymphoma (more on that later) High risk for CJD or vcjd See next slide

CJD/vCJD Deferral Criteria

Question 2 Which of the following is NOT a cause for permanent deferral? A. IV drug abuse B. Male-to-male sex, once in 1976 C. History of Babesiosis or Chagas Disease D. Received drugs for sex once in 1996 E. History of hepatitis at the age of 13

Question 3 Which of the following donors should not be deferred : A. 18 yo college woman. Until 3 months ago, she was living with her mom (close household contact), who had active hepatitis B B. Surgeon who had a needle stick injury 6 months ago, needle was contaminated by a patient who tested negative for hepatitis B, C and HIV C. A man who was arrested after visiting a prostitute 6 months ago, and then released 48h later D. A woman who had a sexual encounter with a IV drug user 3 months ago. E. Young man who got a tattoo 15 months ago

Explanation One year deferral: indirect risk factors for HIV/viral hepatitis;

Question 3 Which of the following donors should not be deferred : A. 18 yo college woman. Until 3 months ago, she was living with her mom (close household contact, who had active hepatitis B B. surgeon who had a needle stick injury 6 months ago, needle was contaminated by a patient who tested negative for hepatitis B, C and HIV C. A man who was arrested after visiting a prostitute, and then released 48h later 6months ago D. A woman who had a sexual encounter with a IV drug user 3 months ago. E. Young man who got a tattoo 15 months ago

Question 4: Which donor is eligible? A. 32 yo missionary, returned from a 2 year trip to a malaria endemic region in S America 14 months ago B. 20 yo college student, born and lived in malaria endemic region in Mexico until 2 years ago. Now studying at UCLA C. 36 yo male, completed a course of malarial treatment 33 months ago after a trip to Africa. Now entirely symptom-free. D. 22 yo UCLA student visited malaria endemic area in Vietnam for 3 months, came back 9 months ago

Explanation: One year deferral: after visiting (staying less than 5 years) a malaria endemic region (refer to the CDC annual yellow book ) http://cdc-malaria.ncsa.uiuc.edu/ Three year deferral: A former resident of an malaria endemic region resident = lived 5 consecutive years or more in the area After completing therapy for malaria

Question 4: Which donor is eligible? A. 32 yo missionary, returned from a 2 year trip to a malaria endemic region in S America 14 months ago B. 20 yo college student, born and lived in malaria endemic region in Mexico until 2 years ago. Now studying at UCLA C. 36 yo male, completed a course of treatment 33 months ago after a trip to Africa. Now entirely symptom free. D. 22 yo UCLA student visited malaria endemic area in Vietnam for 3 months, came back 9 months ago

Question 5 Which donor can donate? A. A 72yo man who had Hodgkin s lymphoma when he was 35, no recurrence after treatment B. 32 yo woman with breast cancer, treated with surgical excision 9 months ago C. 67 yo woman, had basal cell carcinoma lesion excised from cheek a month ago

Explanation: Can malignant cells/clones be transfusion transmitted? No evidence that malignancy can be transmitted by blood transfusion: never been documented and highly unlikely Risk further mitigated by host immune response, leukofiltration and irradiation. Currently, institutional policies vary: permanent deferral if treated with chemo or XRT one to five years after completion of treatment refer to medical director

Generally Most centers accept donors with localized tumors who have been treated; including BCC and localized SCC of skin, cervical carcinoma-in-situ Most centers defer donor non-hematological malignancies for 1 to 5 years after completion of treatment if symptom free and no relapse Permanent deferral usually if history of hematological (leukemia/lymphoma) malignancies. Some centers accept donors with childhood leukemia or lymphoma if treated over 10 years ago

Question 5 Which donor can donate? A. A 72yo man who had Hodgkin s lymphoma when he was 35, no recurrence after treatment A 32 yo woman with breast cancer, treated with surgical excision 9 months ago B. 67 yo woman, had basal cell carcinoma lesion excised from cheek a month ago

Question 6 Which donor can donate? A. Got seasonal IM flu vaccine 10 days ago B. Got MMR 3 weeks ago C. Got oral polio vaccine last week D. Enrolled in a research vaccine trial, got the vaccine 6 months ago E. Got chicken pox (varicella) vaccine 3 weeks ago

Explanation HPV (Gardasil) Shingles MMR * 1. Basic principle of vaccination deferrals: If a vaccine is recombinant, killed or toxoid, there is no deferral. If the vaccine is made of live/attenuated virus or experimental, there is a deferral. 2. * Some places defer donors who received HBV vaccine for 2-4 weeks due to false positive HBSAg donor screening test results

Question 6 Which donor can donate? A. Got seasonal IM flu vaccine 10 days ago B. Got MMR 3 weeks ago C. Got oral polio vaccine last week D. Enrolled in a research vaccine trial, got the vaccine 6 months ago E. Got chicken pox (varicella) vaccine 3 weeks ago

Question 7 Which autologous donor cannot donate? A. Hemoglobin of 12g/dL B. Age 13 C. Age 78 D. History of MI 5 years ago. S/p 3 vessel CABG. Now only on aspirin, asymptomatic, no exercise restrictions E. Has large open decubitus ulcer over sacral area F. Confirmed HIV positive by serology and NAT G. Unit is intended for hip surgery in 4 days

Explanation (1) Autologous donors undergo abbreviated questionnaire. Physical parameters more lenient (see below)

Explanation (2) Collection of autologous unit(s) must be completed 72hr before anticipated surgery Must be ordered by patient s physician Absolute Contraindications: Donor/pt has cardiopulmonary condition and cannot tolerate blood loss well: e.g. recent MI, severe aortic stenosis, ongoing respiratory distress. Donor/pt has high risk of bacteremia Autologous units can NEVER be crossed in to the general inventory even if infectious disease tests are all negative

Question 7 Which autologous donor cannot donate? A. Hemoglobin of 12g/dL B. Age 13 C. Age 78 D. 50 yo male with history of heart attack 5 years ago, s/p 3 vessel CABG. Now only on aspirin, asymptomatic, no exercise restrictions E. Has large open decubitus ulcer F. Confirmed HIV positive by serology and NAT G. Unit is intended for hip surgery in 4 days

Question 8 Which donor can donate now? A. donated whole blood 7 weeks ago B. donated two units of RBCs by apheresis 12 weeks ago C. donated one unit of platelets by apheresis 3 days ago D. donor will be making the 25 th platelet donation within the past 365 days

Explanation Required intervals from last donation; 8 weeks after whole blood/single RBC by apheresis donation 16 weeks after double RBC collections 2 days after donating single unit of platelets by apheresis; 7 days after donating double/triple units of platelets by apheresis Up to 2 apheresis platelet donations within 7 days; up to 24 apheresis platelet donations within a year (365 days)

Question 8 Which donor can donate now? A. donated WB 7 weeks ago B. donated two units of RBCs by apheresis 12 weeks ago C. donated one unit of platelets by apheresis 3 days ago D. will be making the 25 th platelet donation within the past 365 days

Question 9 Which donor can donate now? A. 79 male taking aspirin for joint pain yesterday, who wishes to donate platelets B Donor who took Tegison (etretinate), last dose 3 yrs ago C Donor who took Avodart (dutasteride) 7 months ago D. Donor who took Ticlid(ticlopidine), last dose 10 days ago, wants to donate platelets E. Donor who took human pituitary source growth hormone, last dose five years ago

Explanation The uniform donor questionnaire (UDHQ) only requires questioning about a limited number of medications. Some facilities add more questions and medications to the list.

Teratogens 30 day deferral Accutane, Amnesteem, Claravis, Sotret (isotretinoin) Proscar, Propecia (finasteride) 6 month deferral Avodart, Jalyn (dutasteride) 3 year deferral Soriatane (acitretin) Permanent deferral Tegison (etretinate)

Anti-platelet Agents No deferral if donating plasma, RBC or WB Deferral when donating apheresis platelets: Aspirin, Feldene: Two full medication-free days since last dose Plavix (clopidogrel), Ticlid (ticlodipine): 14 full medication-free days since last dose

Drugs/Therapies with infectious disease risks Growth hormone (human pituitary), bovine insulin: permanent (no case of CJD/vCJD transmission reported to date) HBIg: 1 year (no deferral for IVIg and RhIg) Unlicensed vaccine: 1 year Transfusion: 1 year if transfused in the US, permanent deferral if transfused in the UK

What about antibiotics? Defer if the donor is taking it as treatment or prophylaxis for possible bacteremia. Defer till at least 24-48hrs post completion of therapy. Accept donors taking antibiotics for acne, rosacea

What about anticoagulants and antihypertensives? Many centers defer donors on heparin, warfarin and other anticoagulants because efficacy of plasma is affected, and donor may have impaired hemostasis. ARC: Defer for 7 days after discontinuation of warfarin/coumadin Anti-hypertensives: okay as long as BP is normal on PE

Question 9 Which donor can donate now? A. 79 male taking aspirin for joint pain yesterday, who wishes to donate platelets B Donor who took Tegison (etretinate), last dose 3 yrs ago C Donor who took Avodart (dutasteride) 7 months ago D. Donor who took Ticlid(ticlopidine), last dose 10 days ago E. Donor who took human pituitary source growth hormone, last dose 15 years ago

Question 10:Which of the following about donor testing is true? A. If a donor types as Rh(D) negative, a weak D test is always done to confirm that the patient is truly Rh(D) negative B.Tests done to screen for hepatitis B include HbSAg, anti-hbsag, anti-hbc, and NAT(nuclei acid test) for HBV C. Tests done to screen for HIV include anti- HIV1/2, p24, western blot, NAT for HIV D. Antibody screen is only done on first time donors E. Serological tests are done to screen for antibodies against the following agents: parvo B19, West Nile Virus, Trypanosome cruzi

Testing of Donor Blood ABO and Rh; Weak D is required if donor types as Rh negative Antibody screen: to check for RBC antibodies in donor serum. If positive, cannot use plasma or platelet units from the donor

Testing Donor Blood Infectious Disease Testing HBsAg, anti-hbc are required. HBV NAT not yet required but often done Why is anti-hbsag not done? Anti-HCV, HCV NAT Anti-HIV ½,HIV NAT Anti-HTLV I/II, Serologic tests for syphilis (RPR, MHA-TP) Serologic tests for T. Cruzi (Chagas disese) NAT for WNV

Which of the following about donor testing is true? A. If a donor types as Rh(D) negative, a weak D test is always done to confirm that the patient is truly Rh(D) negative B. Tests done to screen for hepatitis B include HbSAg, anti-hbsag, anti-hbc, and NAT(nucleic acid test) for HBV C.Tests done to screen for HIV include anti- HIV1/2, p24, western blot, NAT for HIV D. Antibody screen is only done on first time donors E. Serological tests are done to screen for antibodies against the following agents: parvo B19, West Nile Virus, Trypanosome cruzi

Question 11 Which of the following about a frequent plasma donor is false? A. Donor donates plasma at least once every two weeks B. Serum protein level needs to be >6g/dL C. SPEP/quantitative immunodiffusion assay should be done once every 4 mo to ensure that plasma fractions are within normal limits D. Physical exam once every year E. At least 2 days between donations, and no more than 2 donations within 7 days.

Question 11 Which of the following about a frequent plasma donor is false? A. Donor donates plasma at least once every two weeks should be q 4wks or more frequently B. Serum protein level needs to be >6g/dL C. SPEP/quantitative immunodiffusion assay should be done once every 4 mo to ensure that plasma fractions are within normal limits D. Physical exam once every year E. At least 2 days between donations, and no more than 2 donations within 7 days.

Miscellaneous Stuff: Female donors who are pregnant should be deferred for weeks after termination of the pregnancy. True or False: United Kingdom includes N. Ireland but not Ireland. Whole blood collected from donors should not exceed ml/kg of body weight, including samples. An asymptomatic donor testing positive for WNV NAT should be deferred for days, or days after symptoms resolve, whichever is later.

Miscellaneous Stuff: Female donors who are pregnant should be deferred for 6 weeks after termination of the pregnancy. True or False: United Kingdom includes N. Ireland but not Ireland. True Ireland is considered as Europe for donor deferral purposes. Whole blood collected from donors should not exceed 10.5ml/kg of body weight, including samples. An asymptomatic donor testing positive for WNV NAT should be deferred for 120 days, or 120 days after symptoms resolve, whichever is later.